Then, fenofibrate might play its endothelial protecting and antiatherosclerosis effect by up-regulating BH4 and GTPCH-I levels in HUVECs, which could provide a new perspective for the therapy of endothelial dysfunction (Figure 4(d)). The gene discussed is GCH1; the disease is endothelial dysfunction.